Emgrast M 500mcg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Sargramostim (500mcg)
Overview Emgrast M 500mcg Injection
Filgrastim 500mcg injection combats infection risk following chemotherapy. This growth factor stimulates bone marrow, boosting white blood cell production crucial for infection defense. Administration is solely by a healthcare professional via injection; dosage and frequency are determined by your physician based on your treatment needs and may vary. Strict adherence to your doctor's instructions is vital; improper use or overdosage carries severe risks. Benefits may take weeks or months to manifest; discontinue use only under medical guidance. Common side effects include bone pain, hypotension, pyrexia, and dyspnea; injection site pain or erythema are also frequent. Report persistent lumps, swelling, or bruising. While it doesn't guarantee complete infection protection, promptly report fever, chills, respiratory distress, pharyngitis, or facial/neck swelling. Inform your healthcare provider of all medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is essential throughout treatment.
Uses of Emgrast M 500mcg Injection
Infectious Disease Prophylaxis Following Chemotherapy
Major Benefits of Emgrast M 500mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Emgrast M 500mcg Injection:
- Bone pain
- Decreased blood pressure
- Fever
- Breathlessness
- Feeling of discomfort
- Vomiting
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Nausea
- Flu-like symptoms
- Rash
- Diarrhea
How to use Emgrast M 500mcg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Emgrast M 500mcg Injection works:
Filgrastim 500mcg injection promotes white blood cell production in the bone marrow, bolstering the body's infection-fighting defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption with Emgrast M 500mcg Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Emgrast M 500mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Consult your physician for advice.
Breast feedingSAFE IF PRESCRIBED
The use of Emgrast M 500mcg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingCONSULT YOUR DOCTOR
Emgrast M 500mcg Injection's impact on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Emgrast M 500mcg Injection to individuals with impaired kidney function requires careful consideration. Dosage modification of Emgrast M 500mcg Injection might be necessary. Physician consultation is recommended. Routine assessment of renal function is advisable during treatment.
LiverCAUTION
The use of Emgrast M 500mcg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Emgrast M 500mcg Injection might be necessary. Physician consultation is recommended. Routine assessment of liver function is advisable during treatment.
What if you forget to take Emgrast M 500mcg Injection :
Should you forget a scheduled dose of Emgrast M 500mcg Injection, seek medical advice.
Facts to Know About Emgrast M 500mcg Injection
| Label | Value |
|---|---|
| Chemical Category | GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Granulocyte-macrophage colony-stimulating factor (GM-CSF) |

